About Nathan Pharma Private Limited
Data last updated:
Nathan Pharma Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24290HP2020PTC008227. Its GSTIN is 02AAHCN2996C1ZL (Himachal Pradesh).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors Amit Kumar Jain and Sumit Jain.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.08 Dic Industrial Area Baddi Distt. Solan Himachal Pardesh, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.87 Lakh. For the same year it recorded a net loss of ₹4.31 Lakh (net margin -111.4%) and EBITDA of -₹4.28 Lakh (EBITDA margin -110.7%).
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹11.46 Cr and satisfied charges of ₹8 Cr on record.
For more details, the company can be reached via its website nathanpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.08 Dic Industrial Area Baddi Distt. Solan Himachal Pardesh, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nathan Pharma Private Limited
The main business activity of Nathan Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Nathan Pharma Private Limited
Nathan Pharma Private Limited is audited by SHARK AND ASSOCIATES CHARTERED ACCOUNTANTS for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHARK AND ASSOCIATES CHARTERED ACCOUNTANTS | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nathan Pharma Private Limited
Nathan Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Jain | Director | 24 Nov 2020 | 5 Years 10 Months | Current |
| Sumit Jain | Director | 24 Nov 2020 | 5 Years 10 Months | Current |
Financials of Nathan Pharma Private Limited FY 2025 filings available
Nathan Pharma Private Limited reported revenue of ₹3.87 Lakh for FY 2024.
Financial Statement Summary of Nathan Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | ₹3.87 Lakh | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹4.28 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.31 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Nathan Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -110.7% | •••• | •••• | •••• |
| Net Profit Margin | -111.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nathan Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nathan Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nathan Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2026 | United Bank of India | ₹44 Lakh | Open |
| 21 Mar 2025 | United Bank of India | ₹11.02 Cr | Open |
| 30 May 2023 | Others | ₹8 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Nathan Pharma Private Limited
Employment history and EPFO contributions of people linked to Nathan Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nathan Pharma Private Limited
Nathan Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAHCN2996C1ZL | Himachal Pradesh | Active | 17 Nov 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nathan Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nathan Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nathan Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nathan Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nathan Pharma Private Limited
Frequently Asked Questions about Nathan Pharma Private Limited
Nathan Pharma is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2020 (6+ years old) and is registered under CIN U24290HP2020PTC008227.
Nathan Pharma reported revenue of ₹3.87 Lakh for FY 2024.
Nathan Pharma has 2 current directors:
- Amit Kumar Jain - Director
- Sumit Jain - Director
Nathan Pharma reported a net loss of ₹4.31 Lakh (net margin -111.4%) and EBITDA of -₹4.28 Lakh (EBITDA margin -110.7%) for FY 2024, as per its filed financial statements.
The GSTIN of Nathan Pharma is 02AAHCN2996C1ZL, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Nathan Pharma is U24290HP2020PTC008227. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nathan Pharma was incorporated on 24 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Nathan Pharma can be reached through the website nathanpharma.com. Its registered office is in Baddi, Himachal Pradesh, India.
The registered office of Nathan Pharma is at Plot No.08 Dic Industrial Area Baddi Distt. Solan Himachal Pardesh, Himachal Pradesh, India – 173205.